TBG Diagnostics $0.270
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 6:57pm | ||||
TBG DIAGNOSTICS LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $58,748,496 (1,168th) |
Close (31-Aug) $0.270 |
Volume (31-Aug) 0 |
Shortsold (12-Dec) 48,223 (0.02%) (429th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.016 |
Notice of Annual General Meeting/Proxy Form
TDL released this announcement to the ASX on 25 June 2021, 15:23. The announcement is not marked as price sensitive, and is 11 page(s) in length and 462.57kb in size.
You can view all announcements from TDL and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from TDL | |
|---|---|
| Removal from Official List - Annual Listing Fees | 30 August 2021, 10:24 |
| Suspension from Official Quotation - Annual Listing Fees | 23 August 2021, 10:33 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 3 August 2021, 10:51 |
| Notice of Annual General Meeting/Proxy Form | 25 June 2021, 15:23 |
| Corporate Restructure and Sale of TBG Inc. Shares Update | 7 June 2021, 9:22 |
| Annual General Meeting | 20 May 2021, 15:07 |
| Quarterly Activities Report and Appendix 4C | 3 May 2021, 13:01 |
If you were already registered, log in here.
If you were already registered, log in here.